...
首页> 外文期刊>The Journal of Cardiovascular Surgery: Official Journal of the International Society for Cardiovascular Surgery >The multicenter experience with a third-generation endovascular device for abdominal aortic aneurysm repair. A report from the EUROSTAR database.
【24h】

The multicenter experience with a third-generation endovascular device for abdominal aortic aneurysm repair. A report from the EUROSTAR database.

机译:使用第三代腔内装置修复腹主动脉瘤的多中心经验。 EUROSTAR数据库的报告。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The purpose of this study was to evaluate the effect of the preoperative diameter of abdominal aortic aneurysms (AAA) upon the midterm outcome obtained by endovascular AAA repair, using a third-generation endovascular device, the Excluder bifurcated endoprosthesis (W. L. Gore & Associates, Inc. Sunnyvale, CA, USA). METHODS: The data of 676 patients, who had undergone endovascular aneurysm repair (EVAR) were analysed. Patients were enrolled over a 6-year period to April 2004 in the EUROSTAR database. Outcomes were compared between 2 groups defined by the preoperative diameter of the aneurysm: group A (n=300), smaller than 5.5 cm; group B (n=376), 5.5 cm or larger. Patient characteristics, details of aorto-iliac anatomy, operative procedure and postoperative complications in the 2 patient groups were compared. Outcome events included aneurysm-related death, overall death, conversion, and late rupture of the aneurysm. Life table analyses and log rank tests were used to compare outcome in the study groups. Multivariate Cox models were used to determine whether baseline and follow-up variables were independently associated with adverse outcomes. RESULTS: Patients in group B were significantly older than patients in group A (73 years vs 71 years respectively; p=0.006), and more frequently were at higher operative risk (ASA-classification >3; 44% vs 59%; p<0.0001). Anatomic differences included a higher incidence of aorto-iliac angulation, a wider and shorter infrarenal neck in group B. Risk factors that were more frequently observed in group B included hypertension, carotid disease and pulmonary disorders. Additional operative events including device migration occurred more frequently in group B (0% vs 2%; p=0.03). Device-related (type I and III combined) endoleaks were more frequently observed at completion arteriography in group B compared to group A (2% vs 4%; p=n.s.). Thirty-day mortality was comparable between the 2 study groups. However, the overall death rate after 3 years of follow-up was significantly higher in patients with larger aneurysms, group B (4% vs 14%; p=0.0025). Similarly, aneurysm-related death was significantly higher in group B (after 3 years 0.3% vs 3%; p=0.02). Aneurysm growth after EVAR was modest low in both study groups (after 2 years 6% vs 8%; non-significant). There was no correlation between growth of the sac and aneurysm-related death. CONCLUSIONS: The midterm outcome after endovascular repair by Excluder devices was satisfactory in patients with small and large AAAs. A higher rate in all-cause deaths and aneurysm-related deaths in patients with larger aneurysms was observed. Post-EVAR aneurysm growth was observed in a small percentage of patients but this did not contribute to aneurysm-related death.
机译:目的:本研究的目的是评估腹主动脉瘤的术前直径对使用第三代血管内装置Excluder叉状内假体(WL Gore&Associates)进行的血管内AAA修复所获得的中期结局的影响(美国加利福尼亚州桑尼维尔)。方法:对676例行血管内动脉瘤修复术(EVAR)的患者进行分析。到2004年4月为止的6年中,患者被纳入EUROSTAR数据库。比较两组根据术前直径确定的结果:A组(n = 300),小于5.5 cm; A组(n = 300)。 B组(n = 376),5.5厘米或更大。比较了两个患者组的患者特征,主动脉-details骨解剖学细节,手术程序和术后并发症。结果事件包括与动脉瘤相关的死亡,整体死亡,转换和动脉瘤的晚期破裂。生命表分析和对数秩检验用于比较研究组的结果。使用多变量Cox模型确定基线和随访变量是否与不良预后独立相关。结果:B组患者显着大于A组患者(分别为73岁和71岁; p = 0.006),且手术风险更高(ASA分类> 3; 44%比59%; p < 0.0001)。 B组的解剖学差异包括主动脉ilia角的发生率较高,肾下颈较宽和较短。B组更常见的危险因素包括高血压,颈动脉疾病和肺部疾病。 B组中包括器械迁移在内的其他手术事件更频繁发生(0%vs 2%; p = 0.03)。与A组相比,B组在完成动脉造影时更经常观察到与设备相关的(I型和III型合并)内漏(2%vs 4%; p = n.s。)。两个研究组的30天死亡率相当。但是,B组大动脉瘤患者3年随访后的总死亡率显着更高(4%vs 14%; p = 0.0025)。同样,B组的动脉瘤相关死亡也明显更高(3年后为0.3%比3%; p = 0.02)。在两个研究组中,EVAR后的动脉瘤生长均处于较低水平(2年后为6%对8%;无统计学意义)。囊的生长与动脉瘤相关的死亡之间没有相关性。结论:使用Excluder装置进行血管内修复后的中期结果对于大小型AAA病人均令人满意。观察到较大动脉瘤患者的全因死亡和与动脉瘤相关的死亡发生率更高。在一小部分患者中观察到了EVAR后动脉瘤的生长,但这并未导致与动脉瘤相关的死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号